KZR-261

KZR-261 · Kezar Life Sciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KZR-261, covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: KZR-261 in Subjects With Advanced Solid Malignancies [Phase 1]